Valuation: Uscom Limited

Market Cap 31.22L 21.62L 19L 17.73L 16.28L 30.47L 21Cr 2.1Cr 82.24L 10Cr 81.18L 79.42L 35Cr P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 44.19L 30.61L 26.89L 25.1L 23.04L 43.13L 29Cr 2.98Cr 1.16Cr 15Cr 1.15Cr 1.12Cr 50Cr EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
1 year 0.01
Extreme 0.011
0.01
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.16
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 07/03/2011
Corporate Secretary 66 24/05/2016
Corporate Officer/Principal - 28/05/2018
Director TitleAgeSince
Chairman - 01/11/2009
Director/Board Member 66 23/08/2018
Director/Board Member 62 16/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%+9.09%-74.47% 21.62L
-2.32%-1.19%+18.49%+3.07% 21TCr
-0.86%+1.54%-4.18%-23.36% 14TCr
-1.11%+6.29%-29.49%+8.78% 12TCr
-2.16%+3.71%-57.67%-12.84% 6.84TCr
+0.12%+2.09%+5.44%+4.27% 4.94TCr
-1.13%+9.11%-24.97%-29.70% 4.76TCr
-1.36%-0.45%+17.84%+14.24% 3.96TCr
-1.68%-1.43%+26.04%+36.47% 3.73TCr
-4.53%+11.87%-3.20%-11.09% 3.27TCr
Average -0.56%+6.40%-4.26%-8.46% 7.52TCr
Weighted average by Cap. -1.59%+7.53%-4.77%-2.65%

Financials

2024 2025
Net sales 37.27L 25.81L 22.68L 21.17L 19.43L 36.37L 25Cr 2.51Cr 98.18L 12Cr 96.91L 94.81L 42Cr 25.79L 17.86L 15.69L 14.65L 13.44L 25.17L 17Cr 1.74Cr 67.94L 8.47Cr 67.06L 65.6L 29Cr
Net income -20.75L -14.37L -12.63L -11.79L -10.82L -20.25L -14Cr -1.4Cr -54.66L -6.81Cr -53.95L -52.78L -24Cr -33.03L -22.88L -20.1L -18.76L -17.22L -32.23L -22Cr -2.22Cr -87.01L -11Cr -85.89L -84.02L -37Cr
Net Debt -15.31L -10.6L -9L -9L -8L -14.94L -10Cr -1.03Cr -40.32L -5.02Cr -39.8L -38.94L -17Cr 12.97L 9L 8L 7L 7L 12.66L 8.61Cr 87.38L 34.17L 4.26Cr 33.73L 33L 15Cr
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35